Sentence examples for subject satisfaction with from inspiring English sources
Subject satisfaction with treatment was based on a 7-point Likert Scale, with 1 being very satisfied and 7 being very dissatisfied.
Daily diary assessments included onset and duration of headache, severity of pain at the time of onset and at treatment, acute headache pain medication(s) usage, study drug usage, associated symptoms, unusual symptoms, and subject satisfaction with treatment.
Secondary endpoints included pain relief, pain freedom, and headache severity at 30, 60, 90, and 120 min postdose, proportion of subjects with relief of associated migraine symptoms (ie, nausea, photophobia, and phonophobia) at 60 min postdose, subject satisfaction with treatment, and use of rescue medication from 2 to 24 h postdose.
These three questionnaires were also administered at each follow-up visit, as was a questionnaire addressing subject satisfaction with footwear and footwear use (Supplementary Appendix 9).
Two patient-reported outcome (PRO) questionnaires (Device-Specific questionnaires I and II) were self-completed at Visits 14 and 28 to assess subject satisfaction with the FlexTouch pen as an additional trial endpoint.
20 Ultimately, time to onset and duration of effect are important factors that have a considerable influence on subject satisfaction with cosmetic treatments, with implications for cost and convenience.
In regard to work shifts, subjects' satisfaction with the morning, evening and night shifts were 62.4%, 64.3% and 63.3%, respectively.
Subjects' satisfaction with treatment was very high throughout the study.
Subjects' satisfaction with treatment was very high throughout the study, and all women stated that they would repeat treatment with the same product.
In previous studies in which the DSA was utilized, six questions were used to evaluate the level of subjects' satisfaction with their removable dentures [ 29– 31].
Subject Satisfaction Ratings Subjects treated with BoNTA had significantly higher satisfaction scores than those treated with placebo at both evaluation time points as well as for the entire study period (p < 0.001).
